Skip to main content

Table 2 Demographic and clinical characteristics

From: Antithrombotic drugs do not increase intraoperative blood loss in emergency gastrointestinal surgery: a single-institution propensity score analysis

 

Before matching

After matching

 

AT

Control

SMD

AT

Control

SMD

Subjects

170

1014

 

113

113

 

Age, years (range)

79 (84–68)

59 (73–33)

1.17

77 (84–69)

77 (84–69)

0.00

Gender, male

101 (59.4)

573 (56.5)

0.04

73 (64.6)

73 (64.6)

0.00

Type of surgery

      

 Gastrectomy

1 (0.6)

11 (1.1)

− 0.14

1 (0.9)

1 (0.9)

0.00

 Patch repair duodenal ulcer

5 (2.9)

56 (5.5)

− 0.05

3 (2.7)

3 (2.7)

0.00

 Intestinal surgery

78 (45.9)

252 (24.9)

− 0.13

60 (53.1)

60 (53.1)

0.00

 Colorectal surgery

42 (24.7)

129 (12.7)

0.45

28 (24.8)

28 (24.8)

0.00

 Stoma creation

18 (10.6)

85 (8.4)

0.31

7 (6.2)

7 (6.2)

0.00

 Appendectomy

23 (13.5)

437 (43.1)

0.08

13 (11.5)

13 (11.5)

0.00

 Cholecystectomy

3 (1.8)

44 (4.3)

− 0.70

1 (0.9)

1 (0.9)

0.00

Surgical approach

      

 Laparotomy

154 (90.6)

60 (59.5)

− 0.15

103 (91.2)

104 (92.0)

− 0.03

 Laparoscopy

16 (9.4)

411 (40.5)

0.77

10 (8.8)

9 (8.0)

0.03

Comorbidities

      

 Diabetes mellitus

43 (25.3)

87 (8.6)

0.46

27 (23.9)

21 (18.6)

0.13

 Renal failure

21 (12.4)

30 (3.0)

0.36

12 (10.6)

4 (3.5)

0.3

 Liver cirrhosis

6 (3.5)

20 (2.0)

0.09

3 (2.7)

3 (2.7)

0.00

 Coronary artery disease

58 (34.1)

9 (0.9)

0.98

36 (31.9)

2 (1.8)

0.88

 Atrial fibrillation

39 (22.9)

18 (1.8)

0.68

26 (23.0)

5 (4.4)

0.57

 Cerebrovascular disease

46 (27.1)

11 (1.1)

0.81

33 (29.2)

4 (3.5)

0.74

 Deep vein thrombosis

14 (8.2)

11 (1.1)

0.34

9 (8.0)

3 (2.7)

0.24

 Hypertension

120 (70.6)

259 (25.5)

1.01

79 (69.9)

51 (45.1)

0.52

 Malignancy

63 (37.1)

208 (20.5)

0.37

35 (31.0)

31 (27.4)

0.08

  1. Data are presented as number (percentage) or median (interquartile)
  2. AT antithrombotic drug group, SMD standardized mean difference